The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation
about
Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acidSMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophyAminoglycosides and other nonsense suppression therapies for the treatment of dystrophinopathySMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCRSpinal muscular atrophy: from gene discovery to clinical trialsA modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophyValidation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and IIIPhase II open label study of valproic acid in spinal muscular atrophyCandidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical studyMechanical dynamics in live cells and fluorescence-based force/tension sensorsConsensus Statement for Standard of Care in Spinal Muscular AtrophyRasch analysis of clinical outcome measures in spinal muscular atrophy.The puzzle of TRPV4 channelopathies.Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study.The motor neuron response to SMN1 deficiency in spinal muscular atrophyAdiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophyAssessing spinal muscular atrophy with quantitative ultrasound.Drug discovery and development for spinal muscular atrophy: lessons from screening approaches and future challenges for clinical development.SMA-MAP: a plasma protein panel for spinal muscular atrophyReliability of the Modified Hammersmith Functional Motor Scale in young children with spinal muscular atrophy.Reliability and validity of the TIMPSI for infants with spinal muscular atrophy type IUpper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trialThe quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients.Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative studyA Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment.Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients.Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool.Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy.A qualitative study of perceptions of meaningful change in spinal muscular atrophyProspective cohort study of spinal muscular atrophy types 2 and 3.Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy.Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network.Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy.Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year.Clinical outcome measures in spinal muscular atrophy.Development and Reliability of the Functional Evaluation Scale for Duchenne Muscular Dystrophy, Gait Domain: A Pilot Study.A natural history study of X-linked myotubular myopathy.Reliability of home-based, motor function measure in hereditary neuromuscular diseasesThigh muscle volume measured by magnetic resonance imaging is stable over a 6-month interval in spinal muscular atrophy.Issues in SMA clinical trial design. The International Coordinating Committee (ICC) for SMA Subcommittee on SMA Clinical Trial Design.
P2860
Q21261395-EC57F541-0036-4EAF-8352-A321F7777784Q21562176-0742BA5C-A5AA-4EFE-822B-AD49BC06A0E0Q24240721-40E5CD09-B9CF-463D-9537-092305DD25CAQ24599124-9E164719-DC7B-4697-9202-98097CA0D49DQ26824894-5E31CE93-26A1-4A65-9390-954B9E894A1BQ28243807-8E44EC4E-5FAA-4491-8EE3-961FD75A82ADQ28248897-91C2A7BA-1A68-48BA-B704-AE7B4DA533E7Q28475498-8510B5D7-8F83-467C-81D8-FBAEBCCDDB5DQ28730283-B815F6B9-7D7B-4752-8224-211998DF0C00Q28834419-3255DE21-6052-4CCE-8266-361C7B9456BBQ29028573-9E60A612-6629-407D-B6F9-1926DA6FE819Q30407124-738D048C-0254-40B6-9F82-0562D4D59A7AQ33355032-1DECCFB9-7F0D-4B35-8075-9E9E9B6B59ACQ33651574-0BD890F0-3B8B-47FE-AEE1-7BDD90E7A103Q33874570-AE4F394A-4016-4154-BD46-859AF8C5E3E8Q33988183-356CF26E-431E-467E-AC13-A0E79A98D52FQ34053266-AA71B21C-3511-4CAB-815F-66A4EE40F30DQ34172502-B01CB25E-9CFB-474B-980E-C81348D41FFBQ34658131-C6F8FA40-99A8-47C9-ADE0-124191E1FD98Q35106119-45F40F62-19C2-4AF4-BF09-D8EAB4E0AF34Q35238315-C398F14A-64C5-4288-8895-7500F6EF50B4Q35364301-CDAADFD7-A270-4443-BEFA-063E15BA3D65Q35754407-A32362E6-9C96-43EB-A98E-94BBC9AC0D84Q35820766-6F19EF07-A03B-4F1E-83B1-FF7FD5C00547Q36043426-432FB1A0-D02E-45A9-B40E-EB6FD0E52468Q36259869-976F2286-D25F-49D4-B54A-E364E410DD4BQ36286233-7F5517DC-FBB6-4EBE-BB6F-1060CE7DF9DAQ36288904-836E61BA-53DD-49BD-AFED-39234C37549AQ36334820-F7E6764A-5DE4-47D1-82EF-BC296DDC261CQ36475291-A0A45A2B-0CCD-453F-91F6-34D44FF7A284Q36761839-736D3F86-86BA-4C1F-9E52-F54CE5ED301CQ37095860-A9A2DB0C-A216-4B65-AF58-A10CA28A0755Q37312480-2311C77E-FDF3-478F-87F6-9EE9E2E1FA28Q37339701-E31EBB92-73FB-414B-9BB3-0EE89E0B5A26Q37513013-EAE163E3-9D70-4AEC-9929-618457225F5EQ38292941-5C126B62-1702-43BB-8EE7-C7EA8F337763Q38607699-D5851B6E-DD80-4AF7-9D4B-F0ECA44ED92DQ38949802-0F23BF6E-439F-452F-B1E3-41BC2413ED1CQ39750156-53CA8887-B925-45A4-A63C-B988E9B3DDC5Q40122857-8A7DBD83-15B7-46D6-9338-32D7B20AD5A0
P2860
The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The Hammersmith functional mot ...... ildren with limited ambulation
@ast
The Hammersmith functional mot ...... ildren with limited ambulation
@en
The Hammersmith functional mot ...... ildren with limited ambulation
@nl
type
label
The Hammersmith functional mot ...... ildren with limited ambulation
@ast
The Hammersmith functional mot ...... ildren with limited ambulation
@en
The Hammersmith functional mot ...... ildren with limited ambulation
@nl
prefLabel
The Hammersmith functional mot ...... ildren with limited ambulation
@ast
The Hammersmith functional mot ...... ildren with limited ambulation
@en
The Hammersmith functional mot ...... ildren with limited ambulation
@nl
P3181
P1476
The Hammersmith functional mot ...... ildren with limited ambulation
@en
P2093
Harvey Kairon
Marion Main
P3181
P356
10.1016/S1090-3798(03)00060-6
P407
P577
2003-01-01T00:00:00Z